← Eichor
Condition: Cardiovascular Events Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Cardiovascular Events

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

OPTIMIZE 5.5 - Optimizing Impella 5.5 Outcomes Through Advanced Data Science
Phase N/A · 1 location(s) · Medical University of Vienna · NCT07619144The Prognostic Value of Anion Gap in Predicting Major Adverse Cardiovascular Events Among Patients With ST-Segment Eleva
Phase N/A · 1 location(s) · Universitas Diponegoro · NCT06586424Procedural Complications and Long-Term Mortality in Complex Coronary Interventions
Phase N/A · 1 location(s) · Istanbul Mehmet Akif Ersoy Educational and Training Hospital · NCT07202754OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardio
Phase 3 · 249 location(s) · Amgen · NCT07136012Apnea, Stroke and Incident Cardiovascular Events
Phase N/A · 1 location(s) · University Hospital, Grenoble · NCT04399200Immune Checkpoint Inhibitor Associated Cardiovascular Adverse Events in Patients With Cancer
Phase N/A · 1 location(s) · Hanneke W. M. van Laarhoven · NCT06519292Risk of Major Adverse Cardiovascular Events for Naldemedine & Other Medications for Opioid Induced Constipation
Phase N/A · 1 location(s) · BioDelivery Sciences International · NCT03720613Cognitive Decline and Underlying Mechanisms in Symptomatic Intracranial Artery Stenosis Patients: A Cohort Study
Phase N/A · 1 location(s) · Anhui Medical University · NCT06336174LAAC-registry: Clinical Outcome After Echocardiography-guided LAA-closure
Phase N/A · 1 location(s) · Insel Gruppe AG, University Hospital Bern · NCT04628078Predictive Value of Glycemic Parameters Measured With the FSL Pro iQ During ACS
NA · 9 location(s) · University Hospital, Montpellier · NCT06014112The CARDIOPROTECT Trial
Phase 2 · 1 location(s) · Beth Israel Deaconess Medical Center · NCT07654426Optimize Risk Prediction After Myocardial Infarction: The ORACLE Study
Phase N/A · 1 location(s) · Fundación Pública Andaluza para la Investigación de Málaga e · NCT06993415Cilostazol and Aspirin for Cardiovascular Event Prevention in Patients With Type 2 Diabetes
Phase 4 · 1 location(s) · Seoul National University Bundang Hospital · NCT07719894A Study to Evaluate Mesenchymal Stem Cell Product StromaForte's Effect on Cardiovascular Events
Phase 1/Phase 2 · 1 location(s) · Cellcolabs Clinical LTD. · NCT06087848Clinical Impact of Intravascular Ultrasound-Based Artificial Intelligence Technologies (INNOVATE-PCI)
Phase N/A · 16 location(s) · Asan Medical Center · NCT05807841Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Ag
Phase 1 · 27 location(s) · AbbVie · NCT06896916Effects of tES Combined With CMDT Gait Training on Cognition, Cortical Activity, Spinal Motoneuron Excitability and Moto
NA · 1 location(s) · Mahidol University · NCT07236216A Study to Evaluate the Efficacy and Safety of BX-001N in Preventing Cardiac Surgery-Associated Acute Kidney Injury (CSA
Phase 2 · 8 location(s) · Bilix Co.,Ltd. · NCT07164833Cardiometabolic evalUation REgistry of Heart Failure
Phase N/A · 1 location(s) · Ruijin Hospital · NCT06939985The Effect of Allopurinol on the Risk of Cardiovascular Events in Patients with Cardiovascular Risk
Phase 3 · 1 location(s) · Poznan University of Medical Sciences · NCT05943821Evaluation of Spironolactone Efficacy in Patient with Rheumatoid Arthritis (RA)
Phase 3 · 1 location(s) · University Hospital, Strasbourg, France · NCT05092984Colchicine in Chronic Kidney Disease Patients
Phase 3 · 1 location(s) · Hospital General Universitario Gregorio Marañon · NCT06998862AI-assisted CT for Risk Stratification in Coronary Artery Disease (ACTION)
Phase N/A · 1 location(s) · University of Galway · NCT07577609A Study to Learn About Heart-Related Risks in Elderly Men With Advanced Prostate Cancer Treated With Enzalutamide or Dar
Phase N/A · 1 location(s) · Bayer · NCT07672119IMPELLA, Complications and Tolerance
Phase N/A · 1 location(s) · University Hospital, Montpellier · NCT06644963Bariatric Surgery for the Reduction of cArdioVascular Events Randomized Controlled Trial
NA · 1 location(s) · Population Health Research Institute · NCT05531474A Study of Real-world Events of Vericiguat in Patients With Chronic Kidney Disease and Heart Failure
NA · 1 location(s) · Guangdong Provincial People's Hospital · NCT07047547Aspirin-free Strategy With Ticagrelor in Patients With a Myocardial Infarction Treated Medically Alone
Phase 3 · 1 location(s) · Montreal Heart Institute · NCT07257198Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
Phase N/A · 7 location(s) · Dana-Farber Cancer Institute · NCT02269592Adverse Drug Events in Patients on Oral Anticoagulation in the Emergency Department
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire de Besancon · NCT06692504
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.